An advisory committee voted narrowly on Thursday to recommend that the Food and Drug Administration reclassify four popular peptide therapies, potentially allowing compounding pharmacies to legally dispense the unapproved substances. According to federal proceedings, the panel’s eight-to-six vote with one abstention followed an 11-hour meeting regarding the substances BPC-157, KPV, and TB-500, while a fourth … Read more
Binghamton University Assistant Professor Jian Zhou, PhD ’18, is leading a five-year, $1.84 million project funded by the National Institutes of Health to develop a dual-sensing ear canal probe for more accurate otoacoustic emissions detection. According to the university, the research team aims to build a prototype within the first three years before advancing to … Read more
Researchers at Carnegie Mellon University, the University of Pittsburgh, and the University of Washington have mapped how 3D genome architecture differs in brain cells affected by Alzheimer’s disease. According to a study published in Science, the research team linked genome folding to gene activity and brain tissue organization using single-cell technology, spatial mapping, and a … Read more
Rapidly developing antibiotic resistance during severe lung infections can occur when patients acquire circular pieces of DNA called plasmids from transient environmental bacteria, according to researchers at the University of Washington School of Medicine. Publishing their findings in Nature Microbiology, the team reported that this gene transfer can cause pathogen resistance to jump more than … Read more
Primary biliary cholangitis is a rare autoimmune disease affecting small bile ducts within the liver, causing bile to build up and trigger progressive liver damage that can eventually lead to cirrhosis, according to recent medical studies. Because the immune system attacks these vital ducts, roughly 40% of patients fail to respond adequately or cannot tolerate … Read more
A study of more than 42,000 U.S. death certificates reveals that mortality rates for people with multiple sclerosis (MS) are rising, with significant disparities linked to race, age, and geography. Research published in the journal Neurology indicates that Black patients experience higher mortality rates at younger ages compared to white patients, while cardiovascular conditions like … Read more
Researchers at the Keck School of Medicine of USC have identified a 3D hierarchy of DNA “enhancers” that function as master switches for prostate cancer development. According to a study published in Genome Biology, these interconnected networks control gene expression, revealing potential new targets for precision cancer therapies that could move beyond current gene-specific treatments. … Read more
University of Virginia researcher Nathan Swami has secured a $1.1 million, four-year grant from the National Institutes of Health to develop microfluidic devices capable of identifying and isolating rare circulating cells. By integrating artificial intelligence with on-chip physical analysis, the project aims to improve diagnostic accuracy for cancer and infectious diseases by capturing cell subpopulations … Read more
Automated AI Evaluation in Clinical Settings: The Human Gap According to a study published in npj Digital Medicine, while AI models offer high internal consistency, they remain insufficient as a total replacement for human oversight in resource-constrained healthcare environments. The Cost-Effectiveness of AI Judging Deploying generative AI for clinical decision support requires rigorous, ongoing validation. … Read more
Researchers at the University of California San Diego and the Rady Children’s Institute for Genomic Medicine have successfully treated two children with SCN2A-related developmental epileptic encephalopathy (DEE) using personalized, allele-selective antisense oligonucleotides (ASOs). According to a study published July 21, 2026, in Nature Medicine, the therapy reduced seizure frequency by up to 90%, improved developmental … Read more